1. The important role played by chemokines influence the clinical outcome of Helicobacter pylori infection
   Abdollah Jafarzadeh et al, 2019, Life Sciences CrossRef
2. CXCL-10: a new candidate for melanoma therapy?
   Hossein Bagheri et al, 2020, Cellular Oncology CrossRef
3. Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies
   Andrew Cannon et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
4. PI3Kδ/γ inhibitor BR101801 extrinsically potentiates effector CD8+T cell-dependent antitumor immunity and abscopal effect after local irradiation
   Yi Na Yoon et al, 2022, Journal for ImmunoTherapy of Cancer CrossRef
5. Functional Analysis of CXCR3 Splicing Variants and Their Ligands Using NanoBiT-Based Molecular Interaction Assays
   Huong Thi Nguyen et al, 2023, Molecules and Cells CrossRef
6. Targeting CXCL9/10/11–CXCR3 axis: an important component of tumor-promoting and antitumor immunity
   Minjie Pan et al, 2023, Clinical and Translational Oncology CrossRef
7. The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer
   Paula T. Kuo et al, 2018, Frontiers in Medicine CrossRef
8. Multifaceted role of chemokines in solid tumors: From biology to therapy
   Sana Raza et al, 2022, Seminars in Cancer Biology CrossRef
9. Involvement of CXC chemokines (CXCL1-CXCL17) in gastric cancer: Prognosis and therapeutic molecules
   Amin Ullah et al, 2024, Life Sciences CrossRef
10. CXC Chemokine Receptors in the Tumor Microenvironment and an Update of Antagonist Development
    Yang Xun et al, 2020, Reviews of Physiology, Biochemistry and Pharmacology CrossRef
11. Targeted splicing therapy: new strategies for colorectal cancer
    Yifeng Zheng et al, 2023, Frontiers in Oncology CrossRef
12. Endogenous CXCL9 affects prognosis by regulating tumor‐infiltrating natural killer cells in intrahepatic cholangiocarcinoma
    Yasunari Fukuda et al, 2020, Cancer Science CrossRef
13. The role of CXCR3 and its ligands in cancer
    Xiaoming Wang et al, 2022, Frontiers in Oncology CrossRef
14. The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells
    Namita Kundu et al, 2019, Breast Cancer: Basic and Clinical Research CrossRef
15. A Network Landscape of HPVOPC Reveals Methylation Alterations as Significant Drivers of Gene Expression via an Immune-Mediated GPCR Signal
    Jesse R. Qualliotine et al, 2023, Cancers CrossRef
16. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
    Ryuma Tokunaga et al, 2018, Cancer Treatment Reviews CrossRef
17. Role of Chemokines in the Biology of Cholangiocarcinoma
    Alessandra Caligiuri et al, 2020, Cancers CrossRef
18. CXCR3 isoform A promotes head and neck cancer progression by enhancing stem‐like property and chemoresistance
    Wan‐Hsuan Sun et al, 2022, Journal of Oral Pathology & Medicine CrossRef
19. Disparate roles of CXCR3A and CXCR3B in regulating progressive properties of colorectal cancer cells
    Hai Li et al, 2019, Molecular Carcinogenesis CrossRef
20. The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment
    Andreas Bikfalvi et al, 2020, American Journal of Physiology-Cell Physiology CrossRef
21. CXCL9, CXCL10, CXCL11/CXCR3 Axis and Immune Activation
    Manzoor Ahmad Mir et al, 2023, Cytokine and Chemokine Networks in Cancer CrossRef
22. The Chemokines Initiating and Maintaining Immune Hot Phenotype Are Prognostic in ICB of HNSCC
    Yuhong Huang et al, 2022, Frontiers in Genetics CrossRef
23. Research progress of CXCR3 inhibitors
    Zhuo Yuan, 2024, Anti-Cancer Drugs CrossRef